Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 10.82 HKD -0.92% Market Closed
Market Cap: 23B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Genscript Biotech Corp
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genscript Biotech Corp
Additional Paid In Capital Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Additional Paid In Capital
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
40%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Additional Paid In Capital
ÂĄ25.5B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Additional Paid In Capital
ÂĄ5.2B
CAGR 3-Years
-5%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Additional Paid In Capital
ÂĄ23B
CAGR 3-Years
-5%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Additional Paid In Capital
ÂĄ10.8B
CAGR 3-Years
-3%
CAGR 5-Years
41%
CAGR 10-Years
41%
W
WuXi XDC Cayman Inc
HKEX:2268
Additional Paid In Capital
ÂĄ4.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genscript Biotech Corp's Additional Paid In Capital?
Additional Paid In Capital
1.9B USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Additional Paid In Capital amounts to 1.9B USD.

What is Genscript Biotech Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
40%

Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for Genscript Biotech Corp have been 16% over the past three years , 40% over the past five years .

Back to Top